BRISTOL-MYERS SQUIBB COMPANY Net Income (Loss) Attributable to Noncontrolling Interest
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Net Income (Loss) Attributable to Noncontrolling Interest of $18.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2023-02-14
- BRISTOL-MYERS SQUIBB COMPANY net income (loss) attributable to noncontrolling interest for the quarter ending 2021-12-31 was $0.00.
- BRISTOL-MYERS SQUIBB COMPANY net income (loss) attributable to noncontrolling interest for the quarter ending 2021-09-30 was $6.00M, a 0.00% change year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY net income (loss) attributable to noncontrolling interest for the quarter ending 2021-06-30 was $6.00M, a 20.00% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY net income (loss) attributable to noncontrolling interest for the quarter ending 2021-03-31 was $8.00M, a 11.11% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY net income (loss) attributable to noncontrolling interest for fiscal 2022 was $18.00M, a 10.00% decline from fiscal 2021.
- BRISTOL-MYERS SQUIBB COMPANY net income (loss) attributable to noncontrolling interest for fiscal 2021 was $20.00M, a 0.00% change from fiscal 2020.
- BRISTOL-MYERS SQUIBB COMPANY net income (loss) attributable to noncontrolling interest for fiscal 2020 was $20.00M, a 4.76% decline from fiscal 2019.
- BRISTOL-MYERS SQUIBB COMPANY net income (loss) attributable to noncontrolling interest for fiscal 2019 was $21.00M, a 22.22% decline from fiscal 2018.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2022-12-31 | $18.00M 10-K · filed 2023-02-14 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $6.00M derived: sum of 2 quarters · filed 2023-02-14 | $12.00M derived: sum of 3 quarters · filed 2023-02-14 | $20.00M 10-K · filed 2023-02-14 |
| 2021-09-30 | $6.00M 10-Q · filed 2021-10-27 | $12.00M derived: sum of 2 quarters · filed 2021-10-27 | $20.00M 10-Q · filed 2021-10-27 | $20.00M derived: sum of 4 quarters · filed 2021-10-27 |
| 2021-06-30 | $6.00M 10-Q · filed 2021-07-28 | $14.00M 10-Q · filed 2021-07-28 | $14.00M derived: sum of 3 quarters · filed 2021-07-28 | $20.00M derived: sum of 4 quarters · filed 2021-10-27 |
| 2021-03-31 | $8.00M 10-Q · filed 2021-04-29 | $8.00M derived: sum of 2 quarters · filed 2021-04-29 | $14.00M derived: sum of 3 quarters · filed 2021-10-27 | $19.00M derived: sum of 4 quarters · filed 2021-10-27 |
| 2020-12-31 | $0.00 10-K · filed 2021-02-10 | $6.00M derived: sum of 2 quarters · filed 2021-10-27 | $11.00M derived: sum of 3 quarters · filed 2021-10-27 | $20.00M 10-K · filed 2023-02-14 |
| 2020-09-30 | $6.00M 10-Q · filed 2021-10-27 | $11.00M derived: sum of 2 quarters · filed 2021-10-27 | $20.00M 10-Q · filed 2021-10-27 | $16.00M derived: sum of 4 quarters · filed 2021-10-27 |
| 2020-06-30 | $5.00M 10-Q · filed 2021-07-28 | $14.00M 10-Q · filed 2021-07-28 | $10.00M derived: sum of 3 quarters · filed 2021-07-28 | $23.00M derived: sum of 4 quarters · filed 2021-07-28 |
| 2020-03-31 | $9.00M 10-Q · filed 2021-04-29 | $5.00M derived: sum of 2 quarters · filed 2021-04-29 | $18.00M derived: sum of 3 quarters · filed 2021-04-29 | $25.00M derived: sum of 4 quarters · filed 2021-04-29 |
| 2019-12-31 | -$4.00M 10-K · filed 2021-02-10 | $9.00M derived: sum of 2 quarters · filed 2021-02-10 | $16.00M derived: sum of 3 quarters · filed 2021-02-10 | $21.00M 10-K · filed 2022-02-09 |
| 2019-09-30 | $13.00M 10-K · filed 2021-02-10 | $20.00M derived: sum of 2 quarters · filed 2021-02-10 | $25.00M 10-Q · filed 2020-11-05 | $23.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | $7.00M 10-K · filed 2021-02-10 | $12.00M 10-Q · filed 2020-08-06 | $10.00M derived: sum of 3 quarters · filed 2021-02-10 | $21.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | $5.00M 10-K · filed 2021-02-10 | $3.00M derived: sum of 2 quarters · filed 2021-02-10 | $14.00M derived: sum of 3 quarters · filed 2021-02-10 | $23.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | -$2.00M 10-K · filed 2020-02-24 | $9.00M derived: sum of 2 quarters · filed 2020-02-24 | $18.00M derived: sum of 3 quarters · filed 2020-02-24 | $27.00M 10-K · filed 2021-02-10 |
| 2018-09-30 | $11.00M 10-K · filed 2020-02-24 | $20.00M derived: sum of 2 quarters · filed 2020-02-24 | $29.00M 10-Q · filed 2019-10-31 | $28.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $9.00M 10-K · filed 2020-02-24 | $18.00M 10-Q · filed 2019-07-25 | $17.00M derived: sum of 3 quarters · filed 2020-02-24 | $28.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $9.00M 10-K · filed 2020-02-24 | $8.00M derived: sum of 2 quarters · filed 2020-02-24 | $19.00M derived: sum of 3 quarters · filed 2020-02-24 | $25.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | -$1.00M 10-K · filed 2019-02-25 | $10.00M derived: sum of 2 quarters · filed 2019-02-25 | $16.00M derived: sum of 3 quarters · filed 2019-02-25 | -$32.00M 10-K · filed 2020-02-24 |
| 2017-09-30 | $11.00M 10-K · filed 2019-02-25 | $17.00M derived: sum of 2 quarters · filed 2019-02-25 | -$31.00M 10-Q · filed 2018-10-25 | -$27.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $6.00M 10-K · filed 2019-02-25 | -$42.00M 10-Q · filed 2018-07-26 | -$38.00M derived: sum of 3 quarters · filed 2019-02-25 | -$25.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | -$48.00M 10-K · filed 2019-02-25 | -$44.00M derived: sum of 2 quarters · filed 2019-02-25 | -$31.00M derived: sum of 3 quarters · filed 2019-02-25 | -$9.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $4.00M 10-K · filed 2018-02-13 | $17.00M derived: sum of 2 quarters · filed 2018-02-13 | $39.00M derived: sum of 3 quarters · filed 2018-02-13 | $50.00M 10-K · filed 2019-02-25 |
| 2016-09-30 | $13.00M 10-K · filed 2018-02-13 | $35.00M derived: sum of 2 quarters · filed 2018-02-13 | $46.00M 10-Q · filed 2017-10-26 | $55.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $22.00M 10-K · filed 2018-02-13 | $33.00M 10-Q · filed 2017-07-27 | $42.00M derived: sum of 3 quarters · filed 2018-02-13 | $66.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $11.00M 10-K · filed 2018-02-13 | $20.00M derived: sum of 2 quarters · filed 2018-02-13 | $44.00M derived: sum of 3 quarters · filed 2018-02-13 | $64.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $9.00M 10-K · filed 2017-02-21 | $33.00M derived: sum of 2 quarters · filed 2017-02-21 | $53.00M derived: sum of 3 quarters · filed 2017-02-21 | $66.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $24.00M 10-K · filed 2017-02-21 | $44.00M derived: sum of 2 quarters · filed 2017-02-21 | $57.00M 10-Q · filed 2016-10-27 | $71.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-06-30 | $20.00M 10-K · filed 2017-02-21 | $33.00M 10-Q · filed 2016-07-28 | $47.00M derived: sum of 3 quarters · filed 2017-02-21 | $58.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-03-31 | $13.00M 10-K · filed 2017-02-21 | $27.00M derived: sum of 2 quarters · filed 2017-02-21 | $38.00M derived: sum of 3 quarters · filed 2017-02-21 | $39.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2014-12-31 | $14.00M 10-K · filed 2016-02-12 | $25.00M derived: sum of 2 quarters · filed 2016-02-12 | $26.00M derived: sum of 3 quarters · filed 2016-02-12 | $25.00M 10-K · filed 2017-02-21 |
| 2014-09-30 | $11.00M 10-K · filed 2016-02-12 | $12.00M derived: sum of 2 quarters · filed 2016-02-12 | $11.00M 10-Q · filed 2015-10-27 | $20.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $1.00M 10-K · filed 2016-02-12 | $0.00 derived: sum of 2 quarters · filed 2016-02-12 | $9.00M derived: sum of 3 quarters · filed 2016-02-12 | $9.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | -$1.00M 10-K · filed 2016-02-12 | $8.00M derived: sum of 2 quarters · filed 2016-02-12 | $8.00M derived: sum of 3 quarters · filed 2016-02-12 | $2.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $9.00M 10-K · filed 2015-02-13 | $9.00M derived: sum of 2 quarters · filed 2015-02-13 | $3.00M derived: sum of 3 quarters · filed 2015-02-13 | $17.00M 10-K · filed 2016-02-12 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | -$6.00M derived: sum of 2 quarters · filed 2015-02-13 | $8.00M 10-Q · filed 2014-10-24 | $7.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | -$6.00M 10-K · filed 2015-02-13 | $8.00M 10-Q · filed 2014-07-24 | $7.00M derived: sum of 3 quarters · filed 2015-02-13 | $5.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | $14.00M 10-K · filed 2015-02-13 | $13.00M derived: sum of 2 quarters · filed 2015-02-13 | $11.00M derived: sum of 3 quarters · filed 2015-02-13 | $174.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | -$1.00M 10-K · filed 2014-02-14 | -$3.00M derived: sum of 2 quarters · filed 2014-02-14 | $160.00M derived: sum of 3 quarters · filed 2014-02-14 | $541.00M 10-K · filed 2015-02-13 |
| 2012-09-30 | -$2.00M 10-K · filed 2014-02-14 | $161.00M derived: sum of 2 quarters · filed 2014-02-14 | $542.00M 10-Q · filed 2013-10-23 | $921.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-06-30 | $163.00M 10-K · filed 2014-02-14 | $544.00M 10-Q · filed 2013-07-25 | $923.00M derived: sum of 3 quarters · filed 2014-02-14 | $1.31B derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-03-31 | $381.00M 10-K · filed 2014-02-14 | $760.00M derived: sum of 2 quarters · filed 2014-02-14 | $1.15B derived: sum of 3 quarters · filed 2014-02-14 | $1.55B derived: sum of 4 quarters · filed 2014-02-14 |
| 2011-12-31 | $379.00M 10-K · filed 2013-02-15 | $765.00M derived: sum of 2 quarters · filed 2013-02-15 | $1.17B derived: sum of 3 quarters · filed 2013-02-15 | $1.55B 10-K · filed 2014-02-14 |
| 2011-09-30 | $386.00M 10-K · filed 2013-02-15 | $791.00M derived: sum of 2 quarters · filed 2013-02-15 | $1.17B 10-Q · filed 2012-10-24 | $1.53B derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-06-30 | $405.00M 10-K · filed 2013-02-15 | $786.00M 10-Q · filed 2012-07-25 | $1.15B derived: sum of 3 quarters · filed 2013-02-15 | $1.50B derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-03-31 | $381.00M 10-K · filed 2013-02-15 | $740.00M derived: sum of 2 quarters · filed 2013-02-15 | $1.09B derived: sum of 3 quarters · filed 2013-02-15 | $1.43B derived: sum of 4 quarters · filed 2013-02-15 |
| 2010-12-31 | $359.00M 10-K · filed 2012-02-17 | $712.00M derived: sum of 2 quarters · filed 2012-02-17 | $1.05B derived: sum of 3 quarters · filed 2012-02-17 | $1.41B 10-K · filed 2013-02-15 |
| 2010-09-30 | $353.00M 10-K · filed 2012-02-17 | $694.00M derived: sum of 2 quarters · filed 2012-02-17 | $1.05B 10-Q · filed 2011-10-27 | $1.38B derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $341.00M 10-K · filed 2012-02-17 | $699.00M 10-Q · filed 2011-07-28 | $1.03B derived: sum of 3 quarters · filed 2012-02-17 | $1.35B derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $358.00M 10-K · filed 2012-02-17 | $686.00M derived: sum of 2 quarters · filed 2012-02-17 | $1.01B derived: sum of 3 quarters · filed 2012-02-17 | $1.32B derived: sum of 4 quarters · filed 2012-02-17 |
| 2009-12-31 | $328.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $652.00M derived: sum of 2 quarters · filed 2012-02-17 | $967.00M derived: sum of 3 quarters · filed 2012-02-17 | $1.25B 10-K · filed 2012-02-17 |
| 2009-09-30 | $324.00M 10-Q · filed 2010-10-26 | $639.00M derived: sum of 2 quarters · filed 2010-10-26 | $922.00M 10-Q · filed 2010-10-26 | $1.19B derived: sum of 4 quarters · filed 2011-02-18 |
| 2009-06-30 | $315.00M 10-Q · filed 2010-07-22 | $598.00M 10-Q · filed 2010-07-22 | $864.00M derived: sum of 3 quarters · filed 2011-02-18 | $1.12B derived: sum of 4 quarters · filed 2011-02-18 |
| 2009-03-31 | $283.00M 10-Q · filed 2010-04-29 | $549.00M derived: sum of 2 quarters · filed 2011-02-18 | $808.00M derived: sum of 3 quarters · filed 2011-02-18 | |
| 2008-12-31 | $266.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $525.00M derived: sum of 2 quarters · filed 2011-02-18 | $996.00M 10-K · filed 2011-02-18 | |
| 2008-09-30 | $259.00M 10-Q · filed 2009-10-22 | $730.00M 10-Q · filed 2009-10-22 | ||
| 2007-12-31 | $763.00M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |